MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial for blood disorder halted early
Disease control TerminatedThis study tested whether adding an experimental drug called sabatolimab to standard treatments could help control a serious blood and bone marrow disorder called myelodysplastic syndrome (MDS). It involved 39 adults with intermediate to very high-risk MDS. The trial was terminat…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Halted trial tests new drug cocktail for aggressive blood disorder
Disease control TerminatedThis study aimed to test the safety and initial effectiveness of a new drug, sabatolimab, when combined with two existing drugs (azacitidine and venetoclax) for adults with high-risk MDS who could not receive intensive chemotherapy or a stem cell transplant. The trial was termina…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC